{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:13:43Z","timestamp":1760098423691,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation","award":["2018KF006"],"award-info":[{"award-number":["2018KF006"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.biopha.2019.109533","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T16:11:33Z","timestamp":1571415093000},"page":"109533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor"],"prefix":"10.1016","volume":"120","author":[{"given":"Fangxian","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijiang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianghe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109533_bib0005","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2019.109533_bib0010","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/mdq277","article-title":"Nasopharyngeal carcinoma","volume":"21","author":"Chan","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2019.109533_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/cco.2016.03.07","article-title":"Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma","volume":"5","author":"Fung","year":"2016","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.biopha.2019.109533_bib0020","first-page":"37","article-title":"Emerging treatment options for nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2019.109533_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/cco.2016.03.03","article-title":"Advances in systemic treatment for nasopharyngeal carcinoma","volume":"5","author":"Tan","year":"2016","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.biopha.2019.109533_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.acr.2015.10.001","article-title":"HSP90 and immune modulation in Cancer","volume":"129","author":"Graner","year":"2016","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109533_bib0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.seminoncol.2006.04.001","article-title":"Heat shock protein 90: a unique chemotherapeutic target","volume":"33","author":"Cullinan","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.biopha.2019.109533_bib0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JTO.0b013e318174ea3a","article-title":"Heat shock protein 90 inhibition in lung cancer","volume":"3","author":"Shimamura","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.biopha.2019.109533_bib0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/157489212801820066","article-title":"Heat shock protein 90 inhibitors as therapeutic agents","volume":"7","author":"Gomez-Monterrey","year":"2012","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.biopha.2019.109533_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000492861","article-title":"Immunophenotypes of ductal epithelial cells in advanced pancreatic ductal adenocarcinoma","volume":"99","author":"Zhou","year":"2019","journal-title":"Digestion"},{"key":"10.1016\/j.biopha.2019.109533_bib0055","article-title":"Clinicopathologic charcterization of sorafenib-induced endoplasmic reticulum stress in human liver cancer cells","volume":"69","author":"Liu","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109533_bib0060","doi-asserted-by":"crossref","first-page":"24201","DOI":"10.1007\/s11356-017-0072-5","article-title":"Effect of acute exposure to PFOA on mouse liver cells in vivo and in vitro","volume":"24","author":"Wu","year":"2017","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.biopha.2019.109533_bib0065","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1002\/jcb.28022","article-title":"Antihepatotoxic benefits of Poria cocos polysaccharides on acetaminophen-lesioned livers in vivo and in vitro","volume":"120","author":"Wu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2019.109533_bib0070","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1002\/jcb.28404","article-title":"Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: analyses of network pharmacology, human and experimental data","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2019.109533_bib0075","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1159\/000482003","article-title":"Biocharacterization of heat shock protein 90 in acetaminophen-treated livers without conspicuous drug induced liver injury","volume":"43","author":"Wu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2019.109533_bib0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijbiomac.2018.03.107","article-title":"Hepatoprotective effects exerted by Poria Cocos polysaccharides against acetaminophen-induced liver injury in mice","volume":"114","author":"Wu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2019.109533_bib0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.etap.2018.12.004","article-title":"Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stress","volume":"65","author":"Su","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109533_bib0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1665-2681(19)30865-8","article-title":"Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites","volume":"13","author":"Liu","year":"2014","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2019.109533_bib0095","first-page":"2477","article-title":"Biological characteristics of heat shock protein 90 in human liver cancer cells","volume":"11","author":"Qin","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2019.109533_bib0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2019.109533_bib0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bcp.2011.11.011","article-title":"Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs","volume":"83","author":"Lu","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109533_bib0110","first-page":"907","article-title":"Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (review)","volume":"46","author":"Sol\u00e1rov\u00e1","year":"2015","journal-title":"Int. J. Oncol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219325934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219325934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:53:16Z","timestamp":1760097196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219325934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"alternative-id":["S0753332219325934"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109533","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109533"}}